Neurology
Stopping Epileptic Seizures With Fewer False Alarms
April 5, 2012 7:41 am | by johnshopkins | Videos | CommentsEpilepsy affects 50 million people worldwide, but in a third of these cases, medication cannot keep seizures from occurring. One solution is to shoot a short pulse of electricity to the brain to stamp out the seizure just as it begins to erupt. But brain implants designed to do this have...
Flipping a Light Switch in the Cell: Quantum Dots Used for Targeted Neural Activation
February 9, 2012 4:59 am | News | CommentsWASHINGTON--(BUSINESS WIRE)--By harnessing quantum dots-tiny light-emitting semiconductor particles a few billionths of a meter across-researchers at the University of Washington (UW) have developed a new and vastly more targeted way to stimulate neurons in the brain.
Sensable Customers Showcase Touch-Enabled Surgical, Medical Simulation and Robotics Innovations at MMVR Conference
February 8, 2012 5:21 am | News | CommentsWILMINGTON, Mass.--(BUSINESS WIRE)--Sensable's customers will feature prominently at the Medicine Meets Virtual Reality (MMVR) Conference in Newport Beach, California beginning tomorrow, where they will showcase innovative haptically-enabled surgical, medical simulation...
NeuroScience Foundation Committed To Advancing Alzheimer's Disease Research In 2012
February 3, 2012 5:26 am | News | CommentsATLANTA--(BUSINESS WIRE)--In 2011, the National Institute of Health spent more than $6 billion on cancer research, compared to less than $480 million on Alzheimer's disease research. Those numbers do not seem alarming until you learn there are over 5.4 million people in the United States...
European Launch Of Penumbra Separator 3D Announced At The Working Group In Interventional Neuroradiology (WIN) Seminar
January 24, 2012 5:03 am | News | CommentsVAL D'ISERE, France--(BUSINESS WIRE)--At last week's ABC-WIN Seminar, Prof. Dr. Michael Knauth, Director of Neuroradiology, University Hospital of Goettingen, Goettingen, Germany, and President-elect of the German Society of Neuroradiology, presented the European evaluation...
FzioMed Receives CE Mark for DYNAVISC Gel
January 24, 2012 4:46 am | News | CommentsSAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--FzioMed, Inc. is pleased to announce that it has received CE Mark approval to market DYNAVISC® adhesion barrier gel in Europe for tendon and peripheral nerve surgery. DYNAVISC is a clear, absorbable gel supplied ready-to-use...
Biotectix Announces First Human Implants of BT DOT Coated Electrodes
January 19, 2012 5:18 am | News | CommentsANN ARBOR, Mich.--(BUSINESS WIRE)--Biotectix, LLC, an Allied Minds, Inc. subsidiary, is pleased to announce the first-in-human (FIH) use of an electrostimulation device incorporating its BT DOT conductive polymer coating technology. Last month, patients were surgically implanted...
InVivo Therapeutics, Geisinger Health System to Conduct Preclinical Study of Injectable Scaffold for Peripheral Nerve Injury For FDA Submission
January 18, 2012 5:45 am | News | CommentsCAMBRIDGE, Mass. & DANVILLE, Pa.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and Geisinger Health System today announced a research collaboration to conduct a preclinical study...
GE Healthcare to Enhance EP Portfolio of Offerings through Biosense Webster Agreement
January 12, 2012 5:08 am | News | CommentsWAUKESHA, Wis.--(BUSINESS WIRE)--GE Healthcare announced today a long-term agreement with Biosense Webster, Inc., in which the companies will co-distribute their leading electrophysiology (EP) systems - including GE's CardioLab* EP Recording Systems and Biosense Webster's...
Parkinson treatment shows positive results in clinical testing
January 11, 2012 5:09 am | News | CommentsGAINESVILLE, Fla. - Researchers from the University of Florida and 14 additional medical centers reported results today in the online version of The Lancet Neurology journal indicating that deep brain stimulation - also known as DBS - is effective at improving motor symptoms...
Data Shows Medtronic AdaptiveStim with RestoreSensor Provides Pain Relief and Convenience
December 12, 2011 4:51 am | News | CommentsMINNEAPOLIS--(BUSINESS WIRE)--Clinical trial data presented at the 15th Annual Meeting of the North American Neuromodulation Society demonstrate the AdaptiveStimâ„¢ with RestoreSensorâ„¢ neurostimulation system from Medtronic provides clinical benefits for many patients...
Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain
December 9, 2011 5:45 am | News | CommentsLAS VEGAS--(BUSINESS WIRE)--Spinal Modulation, a privately held global medical device company, announced today that the Spinal Modulation Neurostimulator System has received the CE Mark for the management of chronic intractable pain. The Spinal Modulation System utilizes low-level electrical signals...
IsoRay Ships First GliaSite Brain Cancer Treatment
November 29, 2011 6:27 am | News | CommentsRICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. announced it has shipped its first GliaSite® radiation therapy system. The Company initiated sales after receiving final approval this week from the State of Washington Department of Health to manufacture its GliaSite® radiation therapy system.
Mid Atlantic Spine and Pain Physicians Perform Region's First Procedure Using New Device from St. Jude Medical
November 16, 2011 5:16 am | News | CommentsELKTON, Md.--(BUSINESS WIRE)--Mid Atlantic Spine and Pain Physicians (MASPP), the most comprehensive pain practice in the U.S. diagnosing and treating spine and pain related disorders, announced today that Dr. Frank J.E. Falco, M.D. performed the region's first procedure using the new Epiducerâ„¢ lead delivery system.
First Comprehensive Study on How Physicians Use Digital Sources to Find Medical Device Information Now Available
November 4, 2011 6:33 am | News | CommentsTORONTO--(BUSINESS WIRE)--Millennium Research Group (MRG), the global authority on medical technology market intelligence, announced today that it will be marketing the Manhattan Research product Digital MedTech Physicianâ„¢, the first data-intense study of how physicians use digital channels...
New Brain Aneurysm Treatment at Stanford Hospital Supplies Hope
November 2, 2011 4:22 am | News | CommentsSTANFORD, Calif.--(BUSINESS WIRE)--If Barbara Maluo's brain aneurysm had been discovered a few months ago, she would have had few viable treatment options. She was one of the 10 to 15 percent of brain aneurysm patients diagnosed each year with aneurysms so large and wide...
Solvay Announces Integra LifeSciences Agreement to Use Eviva® PSU in Integra's Brain Shunt Valves
November 2, 2011 4:06 am | News | CommentsALPHARETTA, Ga., November 1, 2011– Implantable brain shunt valves from Integra LifeSciences Corporation, Plainsboro, N.J., a leading medical device manufacturer, are partially composed of Eviva® polysulfone (PSU) resin from Solvay Specialty Polymers USA, LLC. Eviva PSU resin is part of Solvay's...
Leading Innovator Alpha-Stim Gains Support of Medical Professionals and Patients in Opposing New FDA Rule
October 25, 2011 10:37 am | News | CommentsMINERAL WELLS, Texas--(BUSINESS WIRE)--Alpha-Stim, cranial electrotherapy stimulation (CES) devices providing treatment for anxiety, depression, insomnia and pain, announces its user-supported campaign to change an FDA rule regarding Pre-Market Approval (PMA),
Zynex Ranked 9th in Revenue Growth Among Medical Equipment Companies
October 25, 2011 6:07 am | News | CommentsLONE TREE, Colo.--(BUSINESS WIRE)--Zynex, Inc. (OTCBB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that it has been ranked 127th on Deloitte's 2011 Technology Fast 500 list for revenue growth between 2006 and 2010.
Neurosurgical and Neurovascular Device Market to Grow at Six Percent Per Year
October 25, 2011 6:01 am | News | CommentsTORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the market for the specialized devices used for neurosurgical and neurovascular treatments will grow to $240 million by 2016...
Rock Creek Pharmaceuticals Discloses Further Anatabine Patent Filing
September 20, 2011 6:35 am | by Bio-Medicine.Org | News | CommentsGLEN ALLEN, Va., Sept. 20, 2011 /- Rock Creek Pharmaceuticals, a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX ), announced that on September 19, 2011 a utility patent application was filed with the Patent and Trademark Office ("PTO"). This utility patent application is based on...
Valeant Pharmaceuticals to Refinance Senior Secured Credit Facilities
September 20, 2011 5:36 am | by Bio-Medicine.Org | News | CommentsMISSISSAUGA, Ontario, Sept. 20, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced plans to refinance the existing senior secured credit facilities of its wholly owned subsidiary Valeant Pharmaceuticals International. The existing credit facilities...
'Counting The Cost of Meningitis' Video shows how a signature can help save lives
September 18, 2011 11:35 pm | by RealWire | News | CommentsMeningitis Awareness Week (19-25th September) sees the launch of an online video to support Meningitis Research Foundation's (MRF) Counting the Cost of Meningitis campaign and builds support for vaccination against meningitis and septicaemia. (meningitis.org/sign)MRF is petitioning the UK...
Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference in New York on September 20
September 16, 2011 4:35 am | by Bio-Medicine.Org | News | CommentsPALO ALTO, Calif., Sept. 16, 2011 /- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that the company will make a presentation at the UBS Global Life Sciences Conference in New York on Tuesday, September 20, 2011 at 9:30 a.m. Eastern Time. Company management will provide a...
Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
September 13, 2011 9:36 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Sept. 13, 2011 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the UBS Global Life Sciences Conference in New York. The live presentation takes...
